ZANTAC – CANCER LAWSUIT
ZANTAC – STOMACH AND BLADDER CANCER
Were you or a loved one diagnosed with stomach cancer or bladder cancer after taking Zantac?
The drug company Sandoz Inc., makers of Ranitidine Hydrochloride Capsules 150mg and 300 mg (Zantac), has issued a voluntary recall after confirming that the generic Zantac capsules contained an “unexpected impurity, N-Nitrosodimethylamine (NDMA),” which is a probable human carcinogen.
The U.S. Food and Drug Administration issued an advisory on Sept. 13, 2019, warning the public of a Zantac cancer risk due to chemical contamination of the heartburn medication. Although the FDA advisory states that the level of contamination is “low,” the levels have been found to be between 3,000 and 26,000 times higher than what the agency has determined to be “safe.”
The FDA explained that medicines containing ranitidine, including Zantac (ranitidine), contain trace amounts of n-nitrosodimethylamine (NDMA). Laboratory tests have demonstrated NDMA to be a potent carcinogen. Several Zantac recalls have been issued since contamination was first discovered. The first recall was issued on Sept. 23, 2019 by generic drug maker Sandoz. Several generic Zantac makers have also issued recalls including those that supply Zantac for Walgreens, Walmart, Rite Aid, and CVS. Sanofi, makers of brand name Zantac, also initiated a recall on Oct. 18, 2019. Drugmaker Novartis announced on Sept. 19 that it was stopping distribution of generic Zantac.
FDA officials are saying that people may continue to take Zantac and other ranitidine medications, but those who are on a prescription version should consult with their physicians in order to find out if an alternative treatment is available.
IMPORTANT ZANTAC UPDATE:
The U.S. Food and Drug Administration announced on April 1, 2020 that it is requesting manufacturers to withdraw all Zantac and generic Zantac OTC ranitidine drugs from the market effective immediately. The FDA determined that N-Nitrosodimethylamine (NDMA) in some ranitidine medications “increases over time and when stored at higher than room temperatures and may result in consumer exposure to unacceptable levels…” The FDA, the Environmental Protection Agency (EPA), and the World Health Organization (WHO) all classify NDMA as a cancer-causing substance.
If you developed cancer after taking Zantac, call 844-944-3825 today for a free, no-obligation Zantac lawsuit evaluation.
Duck Law Firm is committed to providing you with the best legal representation available. I have obtained millions on behalf of my consumer clients over the years. However, our success isn’t just measured by the financial compensation we bring in on behalf of our clients. We are also committed consumer advocates who work tirelessly to protect people and the environment from harmful products. Determining liability and proving your case in court can be difficult. To give you and your family the best chance for success, you need a law firm with a winning tradition against major corporations to handle your Zantac lawsuit.
We provide free Zantac case reviews to anyone who fills out our contact form or calls our offices. It costs you nothing out of pocket to retain our law firm to represent you and pursue justice and compensation on your behalf. We don’t see a dime until we win your case.
A Zantac class action lawsuit allows consumers who bought Zantac (ranitidine hcl) to recover the money they spent making that purchase, based on allegations that the manufacturer failed to warn about the risk of NDMA cancer. The makers of Zantac made money by concealing the risks of dangerous Zantac side effects and should be held accountable for misleading consumers about the risk of such side effects.
These class action lawsuits can be filed on behalf of anyone who purchased Zantac and has not developed cancer, but wants to hold the makers accountable for profiting from misleading information.
Zantac personal injury or Zantac wrongful death lawsuits are filed by individuals (or their family members) who developed cancer after taking Zantac. Filing an individual personal injury lawsuit allows people who developed cancer to obtain the maximum possible compensation for their injuries. The law on damages varies from state to state, but there are different kinds of damages that the law allows you to receive, such as those for medical bills, lost wages, pain and suffering, loss of past and future earnings, temporary or permanent disability, and any other compensable damages.
It depends on your claims for damages. For example, if you took Zantac and were diagnosed with some form of cancer (or if a family member took Zantac and was diagnosed with cancer), you may be eligible to file a personal injury lawsuit against the manufacturers of Zantac and/or over-the-counter Zantac (OTC).
An individual personal injury Zantac lawsuit allows people who developed cancer to obtain the maximum possible compensation for their injuries.
Conversely, if you took Zantac and never developed cancer, you could still seek compensation by filing a class action lawsuit against the makers of prescription Zantac and/or Zantac OTC. A Zantac class action lawsuit allows consumers who purchased prescription Zantac or generic Zantac (ranitidine) to recover the money spent on purchasing the medication.
Below are some of the most common Zantac brands and generic ranitidine brand names:
- Zantac 150 Tablets
- Zantac 150 Maximum Strength
- Zantac 150 Maximum Strength Cool Mint
- Zantac 75 Tablets
- Wal-Zan 150
- Wal-Zan 75
- Heartburn Relief (ranitidine)
- Acid Reducer (ranitidine)
- Acid Control (ranitidine)
The link between Zantac and cancer goes back decades. Our firm represents people from across the country with the following Zantac side effects:
- Bladder cancer
- Brain cancer
- Breast cancer
- Esophageal/nasal/throat cancer
- Intestinal cancer
- Kidney cancer
- Liver cancer
- Lung cancer (for non-smokers)
- Ovarian cancer
- Pancreatic cancer
- Prostate cancer
- Stomach cancer
- Testicular cancer
- Thyroid cancer
- Uterine cancer
Other ranitidine Zantac side effects include headaches, abdominal discomfort, nausea and vomiting.
Chemically known as ranitidine hydrochloride, Zantac (ranitidine) belongs to a class of drugs called histamine H2-receptor antagonists (or H2 blockers), which decrease the amount of acid produced by the stomach.
Zantac is a very popular antacid medication that has been on the market since the early 1980s. Zantac is available over the counter (Zantac OTC) and by prescription. People commonly use Zantac for acid reflux, heartburn, and a host of other stomach, throat, and gastrointestinal issues. Others use Zantac for allergies to supplement their treatment regimen.
Zantac dosage varies between 75 and 150 mg tablets, though some patients take a once daily Zantac 300 mg dosage.
Since the 1980s, numerous studies have demonstrated a link between the NDMA in Zantac and cancer. Mounting evidence also allegedly shows that Sanofi and Boehringer Ingelheim, the big pharma companies that make Zantac (ranitidine hydrochloride), concealed the Zantac cancer link from millions of people who took the drug for heartburn, gastric and duodenal ulcers, gastroesophageal reflux disease (GERD), sour stomach, Barrett’s esophagus, acid reflux, and other issues. This deception came as the companies made unprecedented profits from Zantac, the first drug to generate $1 billion in sales.
The U.S. Food and Drug Administration (FDA) announced on September 13, 2019 that it is investigating Zantac cancer risks after testing of Zantac 150 tablets found the commonly-used heartburn medication contains NDMA at levels up to 3,000 times greater than the FDA’s daily intake limit. The Zantac cancer lawyers at Baum Hedlund Aristei & Goldman believe there is no safe level of NDMA.
Prior to the FDA market withdrawal of ranitidine, numerous manufacturers issued generic Zantac recalls on their own, including Apotex, Sandoz (Novartis), and GlaxoSmithKline (GSK) after Valisure, an online pharmacy that batch tests the medications it sells, and Emery Pharma, a contract laboratory, found unacceptably high levels of NDMA in ranitidine during testing. Both filed citizen’s petitions with the FDA, urging the agency to suspend sales and issue a Zantac recall. Some versions of Zantac were also recalled in Canada and Europe.